Target intelligence / Profile preview

Tight junction protein (general family) (null)

Target
null
Molecular classification
Other, Structural protein, Adhesion molecule (for some, e.g., junctional adhesion molecules), Cytoskeletal-interacting protein
01

Overview

Intestinal barrier function proteins, predominantly tight junction proteins such as occludin, claudins, zonula occludens (ZO-1, ZO-2), tricellulin, and junctional adhesion molecules (JAMs), are multiprotein complexes located at the apical aspect of the lateral membrane of intestinal epithelial cells[1][3][5][7]. These proteins seal the paracellular space, regulating the passage of ions, nutrients, water, and blocking the entry of pathogens and toxins[1][5]. Modulation of their expression or structure—by cytokines, metabolic signals, microbiota, and nutrients—can increase or decrease intestinal permeability, and impaired barrier function is implicated in numerous diseases, especially chronic inflammation and metabolic syndromes[2][3][4][5][6][7]. While individual protein family members may be therapeutic targets or biomarkers, "intestinal barrier function proteins" as a group is too broad and not considered a single canonical drug target.

Other names
Intestinal tight junction proteinsTJ proteinsintestinal epithelial barrier proteins
02

Mechanism of action

Drugs or compounds may: - Enhance barrier integrity by upregulating expression or function of TJ proteins (e.g., some polyphenols) - Disrupt barrier by increasing pro-inflammatory cytokines (e.g., TNF-α, IL-6), leading to disassembly or altered phosphorylation of TJ proteins

03

Biological functions

Maintenance of epithelial barrier integrityRegulation of paracellular permeabilityImmune defenseSelective nutrient absorptionSignal transduction (in response to environmental and inflammatory stimuli)
04

Disease associations

Inflammation (e.g., inflammatory bowel disease)InfectionAutoimmune diseaseMetabolic disease (e.g., diabetes, obesity)Liver diseaseOther (including possibly cancer)
05

Safety considerations

Direct targeting for therapeutic purposes is challenging due to:Risk of compromising barrier integrity, increasing infection/sepsis riskPotential systemic immune activation and inflammationOff-target effects due to the broad functional importance of these proteins in health
06

Interacting drugs

Not direct; however, various agents can modulate the expression or function of tight junction proteins, including:

4 more in the full profile.

07

Biomarkers

Expression levels of occludin, claudins (e.g., claudin-2, claudin-1), zonula occludens (ZO-1, ZO-2)Intestinal permeability assays (e.g., lactulose/mannitol ratio)Circulating endotoxin (LPS) levels as surrogate for barrier dysfunction

Beyond the preview

Go deeper on Tight junction protein (general family) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction protein (general family) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call